---
Document Title: G-Rocks™ Adverse Event Reporting Procedure  
File Name: G-Rocks_Adverse_Event_Reporting_Procedure.md  
Classification: INTEL-GRADE // LEVEL-5 SECURE  
Created: 2025-04-03T16:18:29Z  
Document Hashes:
  - SHA256: 479d73c4a87277dcdf1f3e125dfd2e7bbd35c12f4a8fce70a9e8883df5e019f4
  - BLAKE3: 00a2f59e9c96db764582f83d77ef28d6c5305ec508230c2e5a3d918c2161874d
  - SHA512: 0593ef43b2e3a4231743b8d99b8c7edc4b8723ea8e3c50c8e9c9e7e261db10d801edb0e11439a1a383453c6c7f5ea62e3f8b7e5297b4566079f58aa90e1b5d0e
---

## Trademark Notice
G-Rocks™ is a registered trademark. Unauthorized reproduction or use is strictly prohibited.

---

## Purpose
This Standard Operating Procedure (SOP) establishes a secure, traceable, and legally compliant method for receiving, documenting, and evaluating adverse events (AEs) associated with G-Rocks™ crystal supplement products.

---

## Definitions
**Adverse Event (AE):** Any undesirable experience associated with the use of a G-Rocks™ product.
**Serious AE:** Results in death, hospitalization, disability, or significant medical intervention.
**Reporter:** Any user, distributor, or healthcare professional submitting an event.

---

## Reporting Methods
All reports must be submitted within 24 hours of awareness:
- **Encrypted Email:** g-rocks.safety@protonmail.com
- **Offline PDF Submission:** `G-Rocks_AE_Form_v3.pdf` (stored in /secure-reports)
- **Field Agent Logging:** Via QRID form stored on hardware token (for physical bulk vendors only)

---

## Required Report Data
| Field                        | Description                                                   |
|-----------------------------|---------------------------------------------------------------|
| Event Date                  | UTC timestamp of the occurrence                              |
| Product Batch               | e.g., GRX-BTCH-042025                                         |
| Dose Taken                  | Total estimated milligrams used                               |
| Symptoms                    | Include onset, duration, and severity                         |
| Concurrent Medications      | Other substances or medicines used by subject                 |
| Reporter Contact            | Encrypted ID / pseudonym, optional phone                      |

---

## Evaluation & Escalation
1. **Initial Log:** All reports stored with SHA3-512 integrity hash in secure vault (AES-256).
2. **Internal Review:** Reviewed within 48 hours by regulatory lead and QA team.
3. **Trigger Alert Threshold:** If 3+ serious AEs occur from same batch, initiate recall protocol.
4. **External Notification:** If AE is life-threatening, notify FDA MedWatch and applicable international agencies (NMPA, BfArM).

---

## Data Retention & Protection
- All AE reports are archived in immutable storage (WORM-compliant).
- Redacted summaries may be published in quarterly G-Rocks™ Safety Bulletin.

---

## Version Control
| Version | Date         | Editor       | Change Summary                    |
|---------|--------------|--------------|----------------------------------|
| v1.0    | 2025-04-03   | SYSTEM CORE  | Initial CIA-grade implementation |

---

## Audit Log Checkpoint (GPG-Signed)
- Entry #: AE-INIT-0425-001
- Auth Code: `9f8e1a98-b55e-43e6-a72e-d321c4a51088`
- GPG Key ID: `0x88D7GROX1TRK`

---
**This document is protected under international intellectual property laws and internal cyber-regulatory protocols. Reproduction without keyholder authority is punishable by U.S. and international standards.**

